A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
Completed · Phase 3
Conditions studied: Dry Eye Disease
In brief
The purpose of this study is to evaluate the percentage of ocular adverse events reported in subjects with dry eye disease (DED) between the intervention arm (0.003% AR-15512) and control arm (REFRESH® Classic).
Key facts
- Study ID
- NCT06660290
- Run by
- Alcon Research
- People needed
- 55
- Starts
- 2025-01-15
- Expected to finish
- 2025-02-06
- Last updated by the study team
- 2026-03-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Eye Research Foundation — Newport Beach, California, United States
- Vision Institute — Colorado Springs, Colorado, United States
- Andover Eye Associates — Andover, Massachusetts, United States
- Total Eye Care, PA — Memphis, Tennessee, United States
- Advancing Vision Research, LLC — Smyrna, Tennessee, United States
- Piedmont Eye Center — Lynchburg, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.